Biotalys NV
6.7.2026 18:00:00 CEST | Globenewswire | Press release
Biotalys Notice of Publication Half Year 2026 Financial Results and Business Highlights
Biotalys Notice of Publication Half Year 2026 Financial Results and Business Highlights
Webcast and Conference Call to take place on Thursday, 20 August 2026 at 15:00 CET / 14:00 GMT / 09:00 AM ET
Ghent, BELGIUM, July 06, 2026 (GLOBE NEWSWIRE) -- Press release
Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announces that it will publish its financial results and business highlights for the first half of 2026 on Thursday, 20 August 2026 at 07:00 CEST.
Webcast and Conference Call
In addition to the publication of its results, management will host a webcast and conference call followed by a Q&A session, conducted in English. The webcast will be held on Thursday, 20 August 2026 at 15:00 CEST / 14:00 GMT / 09:00 AM ET and can be accessed via the following link:
https://edge.media-server.com/mmc/p/akwx4keo.
To ask live questions to the management, please register for the conference call via the following link: https://register-conf.media-server.com/register/BId80b38a1fd8c4138b1c5532c6fccc499.
A recording of the webcast will be available after the event on the Biotalys investor website: https://www.biotalys.com/investors/financial-information.
About Biotalys
Biotalys is an Agricultural Technology (AgTech) company developing precision biocontrol solutions based on proteins for the protection of crops in both the pre- and post-harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.
For further information, please contact:
Toon Musschoot, Head of IR & Communication
T: +32 (0)9 274 54 00
E: IR@biotalys.com
Attachments
- Press Release_Biotalys_Notice of HY 2026 Results and Business Highlights_ENG
- Persbericht_Biotalys kondigt publicatiedatum aan van financiële resultaten en bedrijfshoogtepunten HY2026
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S6.7.2026 19:58:46 CEST | Press release
Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
Ress Life Investments A/S6.7.2026 19:24:15 CEST | Press release
Major shareholder announcement pursuant to section 30 of the Capital Markets Act.
Vastned NV6.7.2026 18:00:00 CEST | Press release
Disclosure of transparency notification (article 14, first paragraph, of the Law of 2 May 2007)
Zealand Pharma6.7.2026 17:00:00 CEST | Press release
Zealand Pharma - Transactions related to share buy-back program (week 27, 2026)
Brookfield Asset Management Ltd6.7.2026 16:07:25 CEST | Press release
Brookfield Asset Management to Host Second Quarter 2026 Results Conference Call
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom